Hypertension and progression of renal disease

Journal of Nephrology

Volumn 13, Issue 3, 2000, Pages 225-227

  Maschio, Giuseppe ^a   Oldrizzi, Lamberto ^a   Marcantoni, Carmelina ^a   Rugiu, Carlo ^a  

^a UNIVERSITY HOSPITAL OF VERONA   (Italy)

Author keywords

ACE inhibitors; Antihypertensive drugs; Hypertension; Renal disease; Renal protection

Indexed keywords

ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET RESTRICTION; DISEASE COURSE; DRUG MECHANISM; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; KIDNEY DISEASE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; PROTEIN DIET; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL; SURVIVAL TIME;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; DISEASE PROGRESSION; HUMANS; HYPERTENSION; KIDNEY DISEASES;

EID: 0033919189     PISSN: 11218428     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (11)

1. Oldrizzi L, Rugiu C, De Biase V, Maschio G . The place of hypertension among the risk factors for renal function in chronic renal failure. Am J Kidney Dis 1993; 21 (suppl 2): S119-23.
2. Locatelli F, Marcelli D, Comelli M, Locatelli F, Marcelli D, Cornelli M, Alberti D, Graziani G, Buccianti G, Redaelli B, Giangrande A. Proteinuria and blood pressure as causal components of progression to end-stage renal failure. Nephrol Dial Transplant 1996; 11: 461-7.
3. Remuzzi G, Bertani T. Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules? Kidney Int 1990; 38: 384-94.
4. Tarif N, Bakris GL. Preservation of renal function: the spectrum of effects by calcium-channel blockers. Nephrol Dial Transplant 1997; 12: 2244-50.
5. Maschio G, Marcantoni C. Angiotensin converting enzyme inhibitors in nondiabetic renal disease. Curr Opin Nephrol Hypertens 1998; 7: 253-7.
6. Maschio G, Alberti D, Janin G, et al. Effect of the angiotensin-converting enzyme benazepril on the progression of chronic renal insufficiency. N Engl J Med 1996; 334: 939-45.
7. GISEN Group. Randomised, placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non diabetic nephropathy. Lancet 1997; 349: 1857-63.
8. Jafar TH, Landa M, Schmid C. The effect of angiotensin-converting enzyme inhibitors on the progression of non diabetic renal disease: interim results from a pooled analysis of randomized controlled trials. JASN 1998; 9: 378A.
9. Zucchelli P, Zuccalà A, Borghi M, et al. Long-term comparison between captopril and nifedipine in the progression of renal insufficiency. Kidney Int 1992; 42: 452-8.
10. Klahr S, Levey AS, Beck GJ, et al. The effects of dietary protein restriction and blood pressure control on the progression of chronic renal disease. N Engl J Med 1994; 330: 877-84.
11. Maki DD, Ma JZ, Louis TA. Long-term effects of antihypertensive agents on proteinuria and renal function. Arch Intern Med 1995; 155: 1073-80.